Aspirin Falls Short: Clinical Trial Shows No Benefit in Preventing Colorectal Cancer Recurrence
Aspirin, hailed as a wonder drug for its role in preventing heart attacks and strokes, has long been suspected of playing a protective role against certain cancers, including colorectal cancer. However, new evidence from a comprehensive clinical trial has cast doubt on this potential benefit, particularly for patients aiming to prevent the recurrence of colorectal…